title: Ciprofloxacin susceptible Salmonella typhi with treatment failure.
authors.forename: P
authors.initials: P
authors.lastname: Dutta
authors.forename: U
authors.initials: U
authors.lastname: Mitra
authors.forename: S
authors.initials: S
authors.lastname: Datta
authors.forename: M R
authors.initials: MR
authors.lastname: Saha
authors.forename: A
authors.initials: A
authors.lastname: De
authors.forename: K
authors.initials: K
authors.lastname: Roy
authors.forename: M
authors.initials: M
authors.lastname: Basak
authors.forename: S K
authors.initials: SK
authors.lastname: Bhattacharya
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D007194:India; D008826:Microbial Sensitivity Tests; D012485:Salmonella typhi / Q000187:drug effects*; D017211:Treatment Failure; D014435:Typhoid Fever / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D002511:Cephalosporins; D002939:Ciprofloxacin; D002443:Ceftriaxone